Loading...

Lantheus Holdings, Inc.

LNTH•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$84.33
$1.51(1.82%)
U.S. Market opens in NaNh NaNm

Lantheus Holdings, Inc. (LNTH) Stock Overview

Explore Lantheus Holdings, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap5.5B
P/E Ratio23.67
EPS (TTM)$3.41
ROE0.21%
Fundamental Analysis

AI Price Forecasts

1 Month$66.10
3 Months$42.81
1 Year Target$63.08

LNTH Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Lantheus Holdings, Inc. (LNTH) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 63.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $63.08.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 23.67 and a market capitalization of 5.5B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.82%
5-Day Change
0.01%
1-Month Change
13.59%
3-Month Change
24.91%
6-Month Change
50.43%
Year-to-Date (YTD) Change
26.72%
1-Year Change
-18.63%
3-Year Change
-7.55%
5-Year Change
271.17%
All-Time (Max) Change
1145.64%

Contact Information

https://www.lantheus.com
978 671 8001
331 Treble Cove Road, Bedford, MA, 01862

Company Facts

808 Employees
IPO DateJun 25, 2015
CountryUS
Actively Trading

Frequently Asked Questions